Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports
Isomorphic Labs, a drug discovery company spun out from Google DeepMind, is in advanced funding discussions to raise approximately $5 billion. The round would value the company at roughly $50 billion. Bloomberg reported the talks, with sources noting that financing has not yet closed and terms remain subject to change.
Key points
- Isomorphic Labs seeks $5B funding round at $50B valuation
- Company spun out from Google DeepMind for drug discovery
- Deal not yet closed; terms may change
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. The Next Web did the reporting; read the original for the full story.
Read the full story at The Next Web
